Algo version: 0.98b
Oncimmune Holdings PLC is listed at the LSE Exchange
Oncimmune Holdings PLC [ONC.L]
LSE Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Oncimmune Holdings PLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Oncimmune Holdings PLC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP97.00, you would have made a loss of GBP-76.60 per share or -78.97%

Yes, the average daily trading liquidity for Oncimmune Holdings PLC is GBP108 410 thousand. You should therefore be able to get in and out of your positions relatively fast.

Oncimmune Holdings PLC has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. Oncimmune Holdings PLC has a very good net profit margin of 581.63% and should have very high tolerances against inflation.

We have calculated the inflation risk for Oncimmune Holdings PLC to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.